Calcifediol FDA Link

The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.

Also Known As:

Calcidiol; Calderol; 25 Hydroxycholecalciferol; 25-Hydroxycholecalciferol Monohydrate; 25-Hydroxyvitamin D3; Calcifediol Anhydrous; Calcifediol, (3 alpha,5Z,7E)-Isomer; Calcifediol, (3 beta,5E,7E)-Isomer; Dedrogyl; Hidroferol; 25 Hydroxycholecalciferol Monohydrate; 25 Hydroxyvitamin D 3; 25 Hydroxyvitamin D3; Anhydrous, Calcifediol; Monohydrate, 25-Hydroxycholecalciferol; 25-Hydroxycholecalciferol; 25-Hydroxyvitamin D 3; 9,10- Secocholesta- 5,7,10(19)- triene- 3,25- diol, (3beta,5Z,7E)-

Pharmalogical Action Categories:

Bone Density Conservation Agents
Vitamins

Polycyclic Compounds: 7
- Fused-Ring Compounds
  - Steroids: 71426
    - Secosteroids: 22
      - Vitamin D: 34178
        Cholecalciferol: 4907
        Hydroxycholecalciferols: 25
        Calcifediol: 1107
    - Cholestanes
      - Sterols: 2295
        Cholecalciferol: 4907
        Hydroxycholecalciferols: 25
        Calcifediol: 1107
      - Cholestenes
        Cholecalciferol: 4907
        Hydroxycholecalciferols: 25
        Calcifediol: 1107
Lipids: 118169
- Membrane Lipids: 1619
  - Sterols: 2295
    - Cholecalciferol: 4907
      - Hydroxycholecalciferols: 25
        Calcifediol: 1107

Juan M Escudier-Villa Selected Research

Juan M Escudier-Villa Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure